SMTL ID : 6s1f.2 (1 other biounit)

Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.11 Å

Oligo State

homo-dimer

Ligands

2 x KRE: ~{N}-[3-[2-azanyl-5-(4-piperazin-1-ylphenyl)pyridin-3-yl]-5-methoxy-phenyl]methanesulfonamide(Non-covalent)

KRE.1: 19 residues within 4Å: Chain A: L.24, S.25, V.32, A.45, V.46, K.47, L.79, I.93, T.95, E.96, Y.97, M.98, E.105, R.109, Q.150, N.151, L.153, A.163, D.164 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.24, A:V.32, A:V.32, A:L.153 Hydrogen bonds: A:L.24, A:T.95, A:T.95, A:M.98 KRE.2: 21 residues within 4Å: Chain B: L.24, S.25, S.29, V.32, A.45, K.47, E.66, L.79, I.93, T.95, E.96, Y.97, M.98, P.99, G.101, E.105, R.109, N.151, L.153, A.163, D.164 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:V.32, B:V.32, B:A.45, B:K.47, B:L.153 Hydrogen bonds: B:S.29, B:T.95, B:E.96, B:M.98, B:E.105, B:R.109, B:R.109, B:D.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Suebsuwong, C. et al., Design of 3,5-diaryl-2-aminopyridines as receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors. To be published

Release Date

2019-10-16

Peptides

Receptor-interacting serine/threonine-protein kinase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Receptor-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence